{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-16",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Lewisberry",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "99573",
      "recalling_firm": "Nipro Renal Soultions USA, Corporation",
      "address_1": "509 Fishing Creek Rd",
      "address_2": "",
      "postal_code": "17339-9517",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.",
      "recall_number": "Z-3134-2026",
      "product_description": "MedicaLyte Bicarbonate Powder    REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))",
      "product_quantity": "2,327 cases",
      "reason_for_recall": "Hemodialysis concentrates contain high endotoxin levels",
      "recall_initiation_date": "20260805",
      "center_classification_date": "20260910",
      "report_date": "20260916",
      "code_info": "DB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026)",
      "more_code_info": ""
    }
  ]
}